Gongwin Biopharm Holdings Market Cap

Gongwin Biopharm Holdings has a market cap or net worth of 9.27 billion as of March 9, 2026. Its market cap has decreased by -37.15% in one year.

Market Cap

9.27B

Enterprise Value

7.73B

Revenue

37.46M

Ranking

n/a

PE Ratio

n/a

Stock Price

73.50

Market Cap Chart

Since February 8, 2017, Gongwin Biopharm Holdings's market cap has increased from 8.87B to 9.27B, an increase of 4.55%. That is a compound annual growth rate of 0.49%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	9.81B	-7.08%
Dec 31, 2025	10.56B	-26.53%
Dec 31, 2024	14.37B	-31.28%
Dec 29, 2023	20.91B	-42.13%
Dec 30, 2022	36.13B	16.16%
Dec 30, 2021	31.10B	17.15%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEngine	8.78B
TaiGen Biopharmaceuticals Holdings	8.68B
Tanvex BioPharma	11.86B
Medigen Vaccine Biologics	12.10B
Adimmune	7.67B
Ever Supreme Bio Technology	12.66B
Acepodia	7.48B
TCM Biotech International	14.02B

Market Cap Rankings